Your browser doesn't support javascript.
COVID-19, Heart Failure Hospitalizations, and Outcomes: A Nationwide Analysis.
Isath, Ameesh; Malik, Aaqib; Bandyopadhyay, Dhrubajyoti; Goel, Akshay; Hajra, Adrija; Dhand, Abhay; Lanier, Gregg M; Fonarow, Gregg C; Lavie, Carl J; Gass, Alan L.
  • Isath A; Department of Cardiology, Westchester Medical Center and New York Medical College, Valhalla, NY.
  • Malik A; Department of Cardiology, Westchester Medical Center and New York Medical College, Valhalla, NY.
  • Bandyopadhyay D; Department of Cardiology, Westchester Medical Center and New York Medical College, Valhalla, NY.
  • Goel A; Department of Cardiology, Westchester Medical Center and New York Medical College, Valhalla, NY.
  • Hajra A; Department of Medicine, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY.
  • Dhand A; Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY.
  • Lanier GM; Department of Cardiology, Westchester Medical Center and New York Medical College, Valhalla, NY.
  • Fonarow GC; Department of Cardiology, University of California Los Angeles Medical Center, Los Angeles, CA.
  • Lavie CJ; John Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA.
  • Gass AL; Department of Cardiology, Westchester Medical Center and New York Medical College, Valhalla, NY. Electronic address: alan.gass@wmchealth.org.
Curr Probl Cardiol ; 48(4): 101541, 2023 Apr.
Article in English | MEDLINE | ID: covidwho-2231265
ABSTRACT
Heart Failure (HF) patients are at a higher risk of adverse events associated with Coronavirus disease 2019 (COVID-19). Large population-based reports of the impact of COVID-19 on patients hospitalized with HF are limited. The National Inpatient Sample database was queried for HF admissions during 2020 in the United States (US), with and without a diagnosis of COVID-19 based on ICD-10-CM U07. Propensity score matching was used to match patients across age, race, sex, and comorbidities. Multivariate logistic regression analysis was used to identify predictors of mortality. A weighted total of 1,110,085 hospitalizations for HF were identified of which 7,905 patients (0.71%) had a concomitant diagnosis of COVID-19. After propensity matching, HF patients with COVID-19 had higher rate of in-hospital mortality (8.2% vs 3.7%; odds ratio [OR] 2.33 [95% confidence interval [CI] 1.69, 3.21]; P< 0.001), cardiac arrest (2.9% vs 1.1%, OR 2.21 [95% CI 1.24,3.93]; P<0.001), and pulmonary embolism (1.0% vs 0.4%; OR 2.68 [95% CI 1.05, 6.90]; P = 0.0329). During hospitalizations for HF, COVID-19 was also found to be an independent predictor of mortality. Further, increasing age, arrythmias, and chronic kidney disease were independent predictors of mortality in HF patients with COVID-19. COVID-19 is associated with increased in-hospital mortality, longer hospital stays, higher cost of hospitalization and increased risk of adverse outcomes in patients admitted with HF.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Heart Failure Type of study: Diagnostic study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: North America Language: English Journal: Curr Probl Cardiol Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Heart Failure Type of study: Diagnostic study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: North America Language: English Journal: Curr Probl Cardiol Year: 2023 Document Type: Article